New drug NSHO-101 first tested in healthy people for safety
NCT ID NCT07403552
First seen Feb 19, 2026 · Last updated May 10, 2026 · Updated 8 times
Summary
This early-stage study tests the safety and how the body processes a new drug called NSHO-101. About 24 healthy adults will take the drug so researchers can measure its levels in the blood and check for side effects. This study does not aim to treat any disease; it simply gathers important safety information before testing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cenexel Anaheim CA
RECRUITINGAnaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.